enteralogo.png
Entera Bio Reports Q2 2024 Financial Results and Provides Business Updates
August 09, 2024 16:05 ET | Entera Bio Ltd.
JERUSALEM , Aug. 09, 2024 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX), (“Entera” or the “Company”) a leader in the development of orally delivered peptides and small therapeutic proteins,...
enteralogo.png
Entera Bio Announces Full Year 2023 Financial Results and Provides Business Updates
March 08, 2024 16:05 ET | Entera Bio Ltd.
JERUSALEM, March 08, 2024 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX), (“Entera” or the “Company”) a leader in the development of orally delivered peptides, today reported financial results...
enteralogo.png
Entera Bio Adds Sanofi Commercial Leader, Haya Taitel to its Board of Directors
June 07, 2023 07:30 ET | Entera Bio Ltd.
JERUSALEM, June 07, 2023 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX), (“Entera” or the “Company”) a leader in the development of orally delivered peptides and therapeutic proteins, today...